Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells

被引：0
|
作者：
Xiangnan Guan
Ruozhen Hu
Yoonha Choi
Shyam Srivats
Barzin Y. Nabet
John Silva
Lisa McGinnis
Robert Hendricks
Katherine Nutsch
Karl L. Banta
Ellen Duong
Alexis Dunkle
Patrick S. Chang
Chia-Jung Han
Stephanie Mittman
Nandini Molden
Pallavi Daggumati
Wendy Connolly
Melissa Johnson
Delvys Rodriguez Abreu
Byoung Chul Cho
Antoine Italiano
Ignacio Gil-Bazo
Enriqueta Felip
Ira Mellman
Sanjeev Mariathasan
David S. Shames
Raymond Meng
Eugene Y. Chiang
Robert J. Johnston
Namrata S. Patil
机构：
[1] Genentech Inc.,Yonsei Cancer Centre
[2] Sarah Cannon Research Institute/Tennessee Oncology,Faculty of Medicine
[3] PLLC,Clínica Universidad de Navarra
[4] Hospital Universitario Insular de Gran Canaria,undefined
[5] Yonsei University College of Medicine,undefined
[6] Institut Bergonie CLCC Bordeaux,undefined
[7] University of Bordeaux,undefined
[8] CIMA Universidad de Navarra Pamplona,undefined
[9] Vall d’Hebron Institute of Oncology (VHIO),undefined
来源：
Nature | 2024年 / 627卷 / 8005期
关键词：
D O I：
10.1038/s41586-024-07280-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：E11 / E11
相关论文
共 50 条
  • [31] PD-L1 blockade: rejuvenating T cells in CLL
    Kater, Arnon P.
    van der Windt, Gerritje J. W.
    BLOOD, 2015, 126 (02) : 126 - 128
  • [32] THE IMMUNOLOGICAL EFFECT OF PD-L1 BLOCKADE ON DENDRITIC CELLS DERIVED FROM CHRONIC MYELOID LEUKEMIA
    Zhang, L. S.
    Li, L. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 479 - 479
  • [33] Development and characterization of a bispecific antibody (GB265) against PD-L1 and TIGIT
    Huang, Su
    Yang, Riyao
    Huang, Cai
    Putrevu, Saroja
    Fay, Nathan S.
    Wright, Kimberly
    Zaman, Mohd Saif
    Huang, Betty
    Wang, Bo
    Wright, Meredith
    Wang, Yanan
    Tian, Xuefei
    Liu, Yue
    CANCER RESEARCH, 2022, 82 (12)
  • [34] THE TIGIT/CD226/CD155 AXIS AND THE EFFECTS OF COMBINING PD-1/PD-L1 BLOCKADE WITH TIGIT-TARGETING ANTIBODY THERAPY IN SYNGENEIC MURINE GLIOBLASTOMA MODELS
    Gokhale, Prafulla
    Iorgulescu, Bryan
    Klapholz, Max
    Poitras, Michael
    Eschle, Benjamin
    Freeman, Gordon
    Anderson, Ana
    Reardon, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A277 - A278
  • [35] Publisher Correction: Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
    Georgi Tosev
    Wasilijiang Wahafu
    Philipp Reimold
    Ivan Damgov
    Constantin Schwab
    Cem Aksoy
    Adam Kaczorowski
    Albrecht Stenzinger
    Joanne Nyarangi‑Dix
    Markus Hohenfellner
    Stefan Duensing
    Scientific Reports, 11
  • [36] Addition of anti-TIM3 or anti-TIGIT Antibodies to anti-PD1 Blockade Augments Human T cell Adoptive Cell Transfer
    Martinez, Marina
    Kim, Soyeon
    Jean, Naomi St.
    O'Brien, Shaun
    Lian, Lurong
    Sun, Jing
    Verona, Raluca I.
    Moon, Edmund
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [37] Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
    Xianjing Chu
    Wentao Tian
    Ziqi Wang
    Jing Zhang
    Rongrong Zhou
    Molecular Cancer, 22
  • [38] Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer
    Bar, Noffar
    Costa, Federica
    Das, Rituparna
    Duffy, Alyssa
    Samur, Mehmet
    McCachren, Samuel
    Gettinger, Scott N.
    Neparidze, Natalia
    Parker, Terri L.
    Bailur, Jithendra Kini
    Pendleton, Katherine
    Bajpai, Richa
    Zhang, Lin
    Xu, Mina L.
    Anderson, Tara
    Giuliani, Nicola
    Nooka, Ajay
    Cho, Hearn J.
    Raval, Aparna
    Shanmugam, Mala
    Dhodapkar, Kavita M.
    Dhodapkar, Madhav V.
    JCI INSIGHT, 2020, 5 (12)
  • [39] Combined Blockade of TIGIT and PD-L1 Enhances Anti-Neuroblastoma Efficacy of GD2-Directed Immunotherapy with Dinutuximab Beta
    Siebert, Nikolai
    Zumpe, Maxi
    Schwencke, Christian Heinrich
    Biskupski, Simon
    Troschke-Meurer, Sascha
    Leopold, Justus
    Zikoridse, Alexander
    Lode, Holger N.
    CANCERS, 2023, 15 (13)
  • [40] Dendritic cells dictate the responsiveness to PD-L1 blockade in cancer
    Mayoux, M.
    Roller, A.
    Pulko, V
    Chen, S.
    Fransen, M.
    Kowanetz, M.
    Rommel, K.
    Matos, I
    Colombetti, S.
    Belousov, A.
    Karanikas, V
    Hegde, P.
    Chen, D.
    Mellman, I
    Umana, P.
    Perro, M.
    Ossendorp, F.
    Klein, C.
    Xu, W.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 : 22 - 23
12345